Drug General Information (ID: DDIBAUHPSO)
  Drug Name Esmolol Drug Info Levothyroxine Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antihypertensive Agents Antithyroid Agents
  Structure

 Mechanism of Esmolol-Levothyroxine Interaction (Severity Level: Minor)
     Increased metabolism (Unspecific) Click to Show/Hide Mechanism Graph
      Drug Name Esmolol Levothyroxine
      Mechanism Beta blocker Increase in hepatic metabolism of beta blocker by reversing decreased hepatic blood flow associated with hypothyroidism
Increase in hepatic metabolism of beta-blocker by reversing decreased hepatic blood flow associated with hypothyroidism 
      Key Mechanism Factor 1
Factor Name Pharmacokinetics
Factor Description Alters the metabolism of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects.
      Mechanism Description
  • Increased metabolism of Esmolol caused by Levothyroxine 

References
1 Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
2 Aro A, Antila M, Korhonen T, Sundquist H "Pharmacokinetics of propranolol and sotalol in hyperthyroidism." Eur J Clin Pharmacol 21 (1982): 373-7
3 Wells PG, Feely J, Wilkinson GR, Wood AJ "Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing." Clin Pharmacol Ther 33 (1983): 603-8